Stabilization of human urine doping control samples: III. Recombinant human erythropoietin. 2010

M Tsivou, and H A Dimopoulou, and I-P Leontiou, and D G Georgakopoulos, and M A Koupparis, and J Atta-Politou, and C G Georgakopoulos
Doping Control Laboratory of Athens, OAKA, 15123 Maroussi, Greece.

BACKGROUND The tampering of athlete's urine samples by the addition of proteolytic enzymes during the doping control sampling procedure was reported recently. The aim of the current study, funded by the World Anti-Doping Agency (WADA), was the application of a stabilization mixture in urine samples to chemically inactivate proteolytic enzymes and improve the electrophoteric signal of erythropoietin (EPO) in human urine. METHODS The stabilization mixture applied was a combination of antibiotics, antimycotic substances and protease inhibitors. A series of incubation experiments were conducted under controlled conditions in the presence and absence of the stabilization mixture in urine aliquots spiked with six proteases. Two different analytical techniques were applied for the qualitative and quantitative EPO measurement: isoelectric focusing (IEF) and chemiluminescent immunoassay respectively. RESULTS The addition of the chemical stabilization mixture into urine aliquots substantially improved EPO detection in the presence of proteolytic enzymes following incubation at 37 degrees C or storage at -20 degrees C. CONCLUSIONS The results of this study indicated that the stabilization of urine prior to the sample collection procedure with the proposed chemical mixture might prove to be a useful tool for the preservation of anti-doping samples.

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004300 Doping in Sports Illegitimate use of substances for a desired effect in competitive sports. It includes humans and animals. Blood Doping,Sports Blood Doping,Blood Doping, Sports,Blood Dopings,Blood Dopings, Sports,Doping in Sport,Doping, Blood,Dopings, Blood,Dopings, Sports Blood,Sport, Doping in,Sports Blood Dopings,Sports, Doping in,in Sport, Doping,in Sports, Doping
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D054874 Athletic Performance Carrying out of specific physical routines or procedures by one who is trained or skilled in physical activity. Performance is influenced by a combination of physiological, psychological, and socio-cultural factors. Sports Performance,Athletic Performances,Performance, Athletic,Performance, Sports,Performances, Athletic,Performances, Sports,Sports Performances

Related Publications

M Tsivou, and H A Dimopoulou, and I-P Leontiou, and D G Georgakopoulos, and M A Koupparis, and J Atta-Politou, and C G Georgakopoulos
May 2009, Analytical biochemistry,
M Tsivou, and H A Dimopoulou, and I-P Leontiou, and D G Georgakopoulos, and M A Koupparis, and J Atta-Politou, and C G Georgakopoulos
May 2009, Analytical biochemistry,
M Tsivou, and H A Dimopoulou, and I-P Leontiou, and D G Georgakopoulos, and M A Koupparis, and J Atta-Politou, and C G Georgakopoulos
August 2008, Journal of applied physiology (Bethesda, Md. : 1985),
M Tsivou, and H A Dimopoulou, and I-P Leontiou, and D G Georgakopoulos, and M A Koupparis, and J Atta-Politou, and C G Georgakopoulos
January 2007, European journal of mass spectrometry (Chichester, England),
M Tsivou, and H A Dimopoulou, and I-P Leontiou, and D G Georgakopoulos, and M A Koupparis, and J Atta-Politou, and C G Georgakopoulos
June 2020, Drug testing and analysis,
M Tsivou, and H A Dimopoulou, and I-P Leontiou, and D G Georgakopoulos, and M A Koupparis, and J Atta-Politou, and C G Georgakopoulos
April 2004, Therapeutic drug monitoring,
M Tsivou, and H A Dimopoulou, and I-P Leontiou, and D G Georgakopoulos, and M A Koupparis, and J Atta-Politou, and C G Georgakopoulos
May 2017, Drug testing and analysis,
M Tsivou, and H A Dimopoulou, and I-P Leontiou, and D G Georgakopoulos, and M A Koupparis, and J Atta-Politou, and C G Georgakopoulos
June 2019, Journal of pharmaceutical sciences,
M Tsivou, and H A Dimopoulou, and I-P Leontiou, and D G Georgakopoulos, and M A Koupparis, and J Atta-Politou, and C G Georgakopoulos
September 1996, British journal of clinical pharmacology,
M Tsivou, and H A Dimopoulou, and I-P Leontiou, and D G Georgakopoulos, and M A Koupparis, and J Atta-Politou, and C G Georgakopoulos
August 2007, Analytical and bioanalytical chemistry,
Copied contents to your clipboard!